Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 25, 2021
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
[ Tue, May 25th 2021
] - WOPRAI
Yigal Nochomovitz Initiated (SNDX) at Strong Buy and Held Target at $24 on, May 25th, 2021
Yigal Nochomovitz of Citigroup, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $24 on, May 25th, 2021.
Yigal has made no other calls on SNDX in the last 4 months.
There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, all agrees with Yigal's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebowitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $20 on, Wednesday, May 12th, 2021
